The positive correlations of NSE with both short-term and medium-term neuro-cognitive outcome suggests that NSE can be used for selecting patients more prone to cognitive dysfunction, results supported by the data related to higher NSE values in other pathologies associated with the development of cognitive impairment [48, 49]. This evidence concerns the gene ENO2 and Cognitive impairment.